A recent study revealed that ginsenosides could attenuate the expression of cisplatin-inducing PD-L1 in non-small cell lung cancer cells (A549/DDP cells) and enhance the killing activity of T cells against tumor cells (121). Here, CD274 is linked to neoplasm.